A PILOT STUDY OF BEVACIZUMAB-BASED THERAPY IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS AND DIFFUSE INTRINSIC PONTINE GLIOMAS

被引：0
|
作者：
Dorris, Kathleen [1 ]
Wagner, Lars [1 ]
Hummel, Trent [1 ]
Drissi, Rachid [1 ]
Miles, Lili [1 ]
Leach, James [1 ]
Chow, Lionel [1 ]
Turner, Rebecca [1 ]
Gragert, Marsha N. [1 ]
Pruitt, David [1 ]
Sutton, Mary [1 ]
Breneman, John [1 ]
Crone, Kerry [1 ]
Fouladi, Maryam [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [31] Caring for Patients with Newly Diagnosed High-Grade Gliomas
    Grossman, Stuart A.
    Piotrowski, Anna F.
    SEMINARS IN NEUROLOGY, 2016, 36 (04) : 324 - 329
  • [32] Population pharmacokinetic analysis of crizotinib in children with progressive/recurrent high-grade and diffuse intrinsic pontine gliomas.
    Gibson, Elizabeth Grace
    Selvo, Nicholas S.
    Campagne, Olivia
    Gajjar, Amar
    Stewart, Clinton F.
    CANCER RESEARCH, 2021, 81 (13)
  • [33] HIGH-GRADE AND DIFFUSE INTRINSIC PONTINE GLIOMAS IN GREEK PEDIATRIC PATIENTS: FIRST NATIONAL REPORT
    Roka, Kleoniki
    Filippidou, Maria
    Ridola, Vita
    Vlachou, Antonia
    Papadakis, Vassilios
    Nikita, Maria
    Katzilakis, Nikolaos
    Papakonstantinou, Evgenia
    Hatzipantelis, Emmanuel
    Stiakaki, Eftichia
    Polychronopoulou, Sophia
    Baka, Margarita
    Kosmidis, Helen
    Kattamis, Antonis
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S297 - S297
  • [34] Phase III trial of nimotuzumab for the treatment of newly diagnosed diffuse intrinsic pontine gliomas in children and adolescents
    Bode, U.
    Windelberg, M.
    Massimino, M.
    Khuhlaeva, E.
    Warmuth-Metz, M.
    Kortmann, R. D.
    Bach, F.
    Fleischhack, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Phase II Trial of Molecularly Determined Treatment of Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas (DIPG): Feasibility and Safety Update
    Wright, K. D.
    Bandopadhayay, P.
    Goldman, S.
    Rubin, J.
    Leary, S. E.
    Gardner, S.
    Elster, J. D.
    Wang, Z. J.
    Bowers, D.
    Robison, N. J.
    Bendel, A.
    MacDonald, T. J.
    Sandler, E. S.
    Khatib, Z.
    Jabado, N.
    Goumnerova, L.
    Ligon, K.
    Prados, M.
    Gupta, N.
    Kieran, M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S32 - S32
  • [36] Iatrogenic immunosuppression in patients with newly diagnosed high-grade gliomas
    Grossman, S. A.
    Desideri, S.
    Ye, X.
    Szajna, K.
    Chamberlain, M.
    Lesser, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Fotemustine-dacarbacine in newly diagnosed high-grade gliomas
    Hassler, M. R.
    Fazeny-Doerner, B.
    Elandt, K.
    Piribauer, M.
    Preusser, M.
    Hainfellner, J. A.
    Dieckmann, K.
    Rössler, K.
    Marosi, C.
    NEURO-ONCOLOGY, 2006, 8 (04) : 347 - 347
  • [38] Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
    Cohen, Kenneth J.
    Heideman, Richard L.
    Zhou, Tianni
    Holmes, Emiko J.
    Lavey, Robert S.
    Bouffet, Eric
    Pollack, Ian F.
    NEURO-ONCOLOGY, 2011, 13 (04) : 410 - 416
  • [39] The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas
    Gerber, David E.
    Grossman, Stuart A.
    Zeltzman, Michel
    Parisi, Michele A.
    Kleinberg, Lawrence
    NEURO-ONCOLOGY, 2007, 9 (01) : 47 - 52
  • [40] Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas
    Mueller, K.
    Schlamann, A.
    Guckenberger, M.
    Warmuth-Metz, M.
    Glueck, A.
    Pietschmann, S.
    Wawer, A.
    Kortmann, R. -D.
    Kramm, C.
    von Bueren, A. O.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (04) : 377 - 381
12345